Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
- PMID: 11403952
- DOI: 10.1016/s0304-3940(01)01864-x
Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
Abstract
P35 or its truncated fragment p25 is required for cyclin dependent kinase (Cdk)5 activation. It has been reported that p25 is accumulated in the brain of Alzheimer's disease (AD) patients and that p25/Cdk5 induces high phosphorylation of tau and apoptosis in cultured neurons (Nature 402 (1999) 615). Our investigation of AD brain did not show specific accumulation of p25. Exposure to Ca ionophore (A23187) at 10(-6) M induced p25 accumulation in rat primary hippocampal neurons, causing neuronal death without showing hyperphosphorylation of tau. Transgenic mice expressing p25 showed the accumulation of p25 but neither hyperphosphorylation of tau nor neuronal death was shown in these mice. The feature of these mice was the progression of cell growth in pituitary gland. These results suggest that overexpression of p25 lead to the activation of cell cycle but not to the direct phosphorylation of tau.
Similar articles
-
Cdk5 as a drug target for the treatment of Alzheimer's disease.J Mol Neurosci. 2002 Dec;19(3):267-73. doi: 10.1385/JMN:19:3:267. J Mol Neurosci. 2002. PMID: 12540052 Review.
-
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.Neuron. 2003 Oct 30;40(3):471-83. doi: 10.1016/s0896-6273(03)00627-5. Neuron. 2003. PMID: 14642273
-
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.Biochem Biophys Res Commun. 2002 Nov 15;298(5):693-8. doi: 10.1016/s0006-291x(02)02543-3. Biochem Biophys Res Commun. 2002. PMID: 12419309
-
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.Nature. 1999 Dec 9;402(6762):615-22. doi: 10.1038/45159. Nature. 1999. PMID: 10604467
-
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.Arch Med Res. 2012 Nov;43(8):655-62. doi: 10.1016/j.arcmed.2012.10.015. Epub 2012 Nov 7. Arch Med Res. 2012. PMID: 23142263 Free PMC article. Review.
Cited by
-
Physiological and pathological phosphorylation of tau by Cdk5.Front Mol Neurosci. 2014 Jul 15;7:65. doi: 10.3389/fnmol.2014.00065. eCollection 2014. Front Mol Neurosci. 2014. PMID: 25076872 Free PMC article. Review.
-
Reelin signaling and Cdk5 in the control of neuronal positioning.Mol Neurobiol. 2002 Oct-Dec;26(2-3):153-66. doi: 10.1385/MN:26:2-3:153. Mol Neurobiol. 2002. PMID: 12428753 Review.
-
Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease.Front Mol Neurosci. 2009 May 29;2:2. doi: 10.3389/neuro.02.002.2009. eCollection 2009. Front Mol Neurosci. 2009. PMID: 19521544 Free PMC article.
-
Cdk5 as a drug target for the treatment of Alzheimer's disease.J Mol Neurosci. 2002 Dec;19(3):267-73. doi: 10.1385/JMN:19:3:267. J Mol Neurosci. 2002. PMID: 12540052 Review.
-
Tau as a therapeutic target for Alzheimer's disease.Curr Alzheimer Res. 2011 Sep;8(6):666-77. doi: 10.2174/156720511796717195. Curr Alzheimer Res. 2011. PMID: 21679154 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials